Neuwelt et al. have proposed gene-transfer experiments utilizing an an
imal model that offers many important advantages for investigating the
feasibility of gene therapy in the human brain. A variety of tissues
concerning the viral vector and mode of delivery of the corrective gen
es need to be resolved, however, before such therapy is scientifically
supportable.